Literature DB >> 28391624

Nitric oxide in the pathophysiology of retinopathy: evidences from preclinical and clinical researches.

Radka Opatrilova1, Peter Kubatka2,3, Martin Caprnda4, Dietrich Büsselberg5, Vladimir Krasnik6, Pavol Vesely7, Sandeep Saxena8, Surabhi Ruia8, Ioana Mozos9, Luis Rodrigo10, Peter Kruzliak1, Katia Goncalves Dos Santos11,12.   

Abstract

Retinopathy is the leading cause of blindness and visual disability in working-aged people. The pathogenesis of retinopathy is an actual and still open query. Alterations contributing to oxidative and nitrosative stress, including elevated nitric oxide and superoxide production, changes in the expression of different isoforms of nitric oxide synthase or endogenous antioxidant system, have been implicated in the mechanisms how this ocular disease develops. In addition, it was documented that renin-angiotensin system has been implicated in the progression of retinopathy. Based on comprehensive preclinical and clinical researches in this area, the role of above-mentioned factors in the pathogenesis of diabetic retinopathy, hypertensive retinopathy and ischaemic proliferative retinopathy is reviewed in this study. Moreover, the genetic susceptibility factors involved in the development of the retinopathy and possible strategies that utilize antioxidants as additive therapy are also highlighted here.
© 2017 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  antioxidant therapy; diabetic retinopathy; gene polymorphism; hypertensive retinopathy; ischaemic proliferative retinopathy; nitric oxide; nitric oxide synthase

Mesh:

Substances:

Year:  2017        PMID: 28391624     DOI: 10.1111/aos.13384

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  23 in total

1.  Network pharmacology and molecular docking study on the active ingredients of qidengmingmu capsule for the treatment of diabetic retinopathy.

Authors:  Mingxu Zhang; Jiawei Yang; Xiulan Zhao; Ying Zhao; Siquan Zhu
Journal:  Sci Rep       Date:  2021-04-01       Impact factor: 4.379

2.  Altered transsulfuration pathway enzymes and redox homeostasis in inherited retinal degenerative diseases.

Authors:  Alireza Badiei; William A Beltran; Gustavo D Aguirre
Journal:  Exp Eye Res       Date:  2021-12-23       Impact factor: 3.467

Review 3.  Lycopene and Vascular Health.

Authors:  Ioana Mozos; Dana Stoian; Alexandru Caraba; Clemens Malainer; Jarosław O Horbańczuk; Atanas G Atanasov
Journal:  Front Pharmacol       Date:  2018-05-23       Impact factor: 5.810

Review 4.  Microglia Contribution to the Regulation of the Retinal and Choroidal Vasculature in Age-Related Macular Degeneration.

Authors:  C Henrique Alves; Rosa Fernandes; Ana Raquel Santiago; António Francisco Ambrósio
Journal:  Cells       Date:  2020-05-14       Impact factor: 6.600

5.  A genome-wide association study suggests new evidence for an association of the NADPH Oxidase 4 (NOX4) gene with severe diabetic retinopathy in type 2 diabetes.

Authors:  Weihua Meng; Kaanan P Shah; Samuela Pollack; Iiro Toppila; Harry L Hebert; Mark I McCarthy; Leif Groop; Emma Ahlqvist; Valeriya Lyssenko; Elisabet Agardh; Mark Daniell; Georgia Kaidonis; Jamie E Craig; Paul Mitchell; Gerald Liew; Annette Kifley; Jie Jin Wang; Mark W Christiansen; Richard A Jensen; Alan Penman; Heather A Hancock; Ching J Chen; Adolfo Correa; Jane Z Kuo; Xiaohui Li; Yii-der I Chen; Jerome I Rotter; Ronald Klein; Barbara Klein; Tien Y Wong; Andrew D Morris; Alexander S F Doney; Helen M Colhoun; Alkes L Price; Kathryn P Burdon; Per-Henrik Groop; Niina Sandholm; Michael A Grassi; Lucia Sobrin; Colin N A Palmer
Journal:  Acta Ophthalmol       Date:  2018-09-04       Impact factor: 3.761

Review 6.  Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology.

Authors:  Olvera-Montaño Cecilia; Castellanos-González José Alberto; Navarro-Partida José; Cardona-Muñoz Ernesto Germán; López-Contreras Ana Karen; Roman-Pintos Luis Miguel; Robles-Rivera Ricardo Raúl; Rodríguez-Carrizalez Adolfo Daniel
Journal:  J Diabetes Res       Date:  2019-08-14       Impact factor: 4.011

7.  iNOS-inhibitor driven neuroprotection in a porcine retina organ culture model.

Authors:  José Hurst; Ana Maria Mueller-Buehl; Lisa Hofmann; Sandra Kuehn; Fenja Herms; Sven Schnichels; Stephanie Christine Joachim
Journal:  J Cell Mol Med       Date:  2020-03-04       Impact factor: 5.310

8.  Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation.

Authors:  Miguel Alejandro Lopez-Ramirez; Catherine Chinhchu Lai; Shady Ibrahim Soliman; Preston Hale; Angela Pham; Esau J Estrada; Sara McCurdy; Romuald Girard; Riya Verma; Thomas Moore; Rhonda Lightle; Nicholas Hobson; Robert Shenkar; Orit Poulsen; Gabriel G Haddad; Richard Daneman; Brendan Gongol; Hao Sun; Frederic Lagarrigue; Issam A Awad; Mark H Ginsberg
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

9.  Establishment of a Rapid Lesion-Controllable Retinal Degeneration Monkey Model for Preclinical Stem Cell Therapy.

Authors:  Guanjie Gao; Liwen He; Shengxu Liu; Dandan Zheng; Xiaojing Song; Wenxin Zhang; Minzhong Yu; Guangwei Luo; Xiufeng Zhong
Journal:  Cells       Date:  2020-11-13       Impact factor: 6.600

Review 10.  The Role of Inflammation in Diabetic Retinopathy.

Authors:  John V Forrester; Lucia Kuffova; Mirela Delibegovic
Journal:  Front Immunol       Date:  2020-11-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.